Skip to content

Alembic Pharma falls 5% after board nod to Rs 1,150-cr impairment charges

Shares of Alembic Pharma hit a fresh 52-week low after the company’s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.

Read More

​ Shares of Alembic Pharma hit a fresh 52-week low after the company’s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat. Shares of Alembic Pharma hit a fresh 52-week low after the company’s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish